US Stock MarketDetailed Quotes

SLN Silence Therapeutics

Watchlist
  • 21.820
  • +0.230+1.07%
Close Mar 27 16:00 ET
1.01BMarket Cap-14614P/E (TTM)

Silence Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
13.43%-39.35M
11.50%-11.87M
48.19%-4.87M
-80.89%-14.96M
46.74%-7.66M
-767.88%-45.46M
-508.07%-13.41M
-90.87%-9.4M
-131.76%-8.27M
-18.88%-14.38M
Net income from continuing operations
-6.21%-50.31M
0.56%-14.97M
-14.31%-10.66M
10.51%-12.01M
-32.40%-12.67M
-3.30%-47.37M
-34.05%-15.05M
22.61%-9.33M
-5.60%-13.42M
3.02%-9.57M
Operating gains losses
202.52%2.16M
23.80%1.17M
363.72%596K
368.97%312K
-26.32%84K
133.77%713K
77.21%941K
23.39%-226K
-111.87%-116K
112.56%114K
Depreciation and amortization
3.32%498K
-14.18%121K
9.65%125K
3.51%118K
18.58%134K
12.88%482K
113.64%141K
3.64%114K
-7.32%114K
-11.72%113K
Other non cash items
155.50%706K
-59.10%1.67M
52.92%-2.04M
182.66%553K
249.71%524K
-3,128.57%-1.27M
11,422.22%4.08M
-1,765.95%-4.33M
-205.48%-669K
-166.16%-350K
Change In working capital
-41.14%-11.66M
78.38%-1.13M
86.16%3.67M
-350.83%-6.93M
6.24%-7.27M
-121.27%-8.26M
-179.18%-5.24M
261.17%1.97M
-92.14%2.76M
-124.03%-7.76M
-Change in receivables
-34.25%-1.46M
108.94%115K
273.08%10.34M
-3,296.33%-11.11M
64.11%-805K
-103.95%-1.09M
29.40%-1.29M
532.65%2.77M
-100.98%-327K
48.99%-2.24M
-Change in payables and accrued expense
-96.96%44K
132.86%757K
-96.89%94K
-132.03%-1.23M
113.52%419K
-39.83%1.45M
-269.29%-2.3M
121.07%3.02M
253.14%3.83M
-120.26%-3.1M
-Change in other current assets
53.37%-1.97M
-165.55%-392K
-124.63%-4.55M
176.41%1.61M
298.25%1.36M
-818.54%-4.23M
122.66%598K
-380.22%-2.03M
-219.06%-2.11M
-193.84%-686K
-Change in other working capital
-88.18%-8.28M
28.25%-1.61M
-23.12%-2.21M
176.31%3.79M
-377.20%-8.25M
-152.56%-4.4M
-123.13%-2.25M
9.43%-1.8M
240.00%1.37M
-207.26%-1.73M
Cash from discontinued investing activities
Operating cash flow
13.43%-39.35M
11.50%-11.87M
48.19%-4.87M
-80.89%-14.96M
46.74%-7.66M
-767.88%-45.46M
-508.07%-13.41M
-90.87%-9.4M
-131.76%-8.27M
-18.88%-14.38M
Investing cash flow
Cash flow from continuing investing activities
199.32%16.43M
102.33%382K
49,214.29%20.63M
-13,351.43%-4.71M
350.98%128K
-290.66%-16.54M
-468.69%-16.41M
-100.90%-42K
91.97%-35K
-292.31%-51K
Net PPE purchase and sale
67.86%-45K
66.67%-1K
57.45%-20K
103.33%3K
---27K
89.32%-140K
99.43%-3K
85.80%-47K
79.50%-90K
--0
Net intangibles purchase and sale
--0
----
----
----
---6K
-1,204.35%-300K
----
----
----
--0
Net investment purchase and sale
196.23%15.52M
--0
--20.1M
-229,150.00%-4.59M
--0
-261.25%-16.13M
-422.50%-16.13M
--0
---2K
--2K
Cash from discontinued investing activities
Investing cash flow
199.32%16.43M
102.33%382K
49,214.29%20.63M
-13,351.43%-4.71M
350.98%128K
-290.66%-16.54M
-468.69%-16.41M
-100.90%-42K
91.97%-35K
-292.31%-51K
Financing cash flow
Cash flow from continuing financing activities
-41.57%25.16M
22,445.45%9.92M
-72.06%12.03M
29,045.45%3.18M
140.43%19K
40.17%43.05M
44K
10,032.47%43.06M
82.26%-11K
-100.15%-47K
Net issuance payments of debt
8.42%-174K
44.87%-43K
-226.67%-49K
32.00%-34K
-2.13%-48K
9.95%-190K
-7,700.00%-78K
-103.69%-15K
90.04%-50K
58.77%-47K
Net common stock issuance
-41.42%25.33M
8,066.39%9.96M
-71.96%12.08M
8,151.28%3.22M
--67K
39.83%43.24M
12,100.00%122K
226,626.32%43.08M
-91.14%39K
--0
Cash from discontinued financing activities
Financing cash flow
-41.57%25.16M
22,445.45%9.92M
-72.06%12.03M
29,045.45%3.18M
140.43%19K
40.17%43.05M
--44K
10,032.47%43.06M
82.26%-11K
-100.15%-47K
Net cash flow
Beginning cash position
-25.46%54.82M
-34.67%58.81M
-42.36%29.72M
-21.19%46.73M
-25.46%54.82M
167.90%73.54M
25.95%90.02M
-27.62%51.57M
29.67%59.3M
167.90%73.54M
Current changes in cash
111.79%2.24M
94.75%-1.56M
-17.34%27.79M
-98.22%-16.48M
48.12%-7.51M
-141.02%-18.95M
-1,425.23%-29.78M
19,559.06%33.62M
-132.56%-8.31M
-179.34%-14.47M
Effect of exchange rate changes
-1,424.56%-3.02M
40.68%-3.22M
-73.03%1.3M
-190.92%-531K
-348.28%-576K
317.14%228K
-2,929.61%-5.42M
7,958.33%4.84M
2,880.95%584K
562.86%232K
End cash Position
-1.43%54.03M
-1.43%54.03M
-34.67%58.81M
-42.36%29.72M
-21.19%46.73M
-25.46%54.82M
-25.46%54.82M
25.95%90.02M
-27.62%51.57M
29.67%59.3M
Free cash flow
14.16%-39.4M
13.45%-11.87M
48.24%-4.89M
-78.83%-14.95M
46.52%-7.69M
-938.74%-45.9M
-397.68%-13.71M
-79.75%-9.45M
-132.66%-8.36M
-18.74%-14.38M
Currency Unit
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 13.43%-39.35M11.50%-11.87M48.19%-4.87M-80.89%-14.96M46.74%-7.66M-767.88%-45.46M-508.07%-13.41M-90.87%-9.4M-131.76%-8.27M-18.88%-14.38M
Net income from continuing operations -6.21%-50.31M0.56%-14.97M-14.31%-10.66M10.51%-12.01M-32.40%-12.67M-3.30%-47.37M-34.05%-15.05M22.61%-9.33M-5.60%-13.42M3.02%-9.57M
Operating gains losses 202.52%2.16M23.80%1.17M363.72%596K368.97%312K-26.32%84K133.77%713K77.21%941K23.39%-226K-111.87%-116K112.56%114K
Depreciation and amortization 3.32%498K-14.18%121K9.65%125K3.51%118K18.58%134K12.88%482K113.64%141K3.64%114K-7.32%114K-11.72%113K
Other non cash items 155.50%706K-59.10%1.67M52.92%-2.04M182.66%553K249.71%524K-3,128.57%-1.27M11,422.22%4.08M-1,765.95%-4.33M-205.48%-669K-166.16%-350K
Change In working capital -41.14%-11.66M78.38%-1.13M86.16%3.67M-350.83%-6.93M6.24%-7.27M-121.27%-8.26M-179.18%-5.24M261.17%1.97M-92.14%2.76M-124.03%-7.76M
-Change in receivables -34.25%-1.46M108.94%115K273.08%10.34M-3,296.33%-11.11M64.11%-805K-103.95%-1.09M29.40%-1.29M532.65%2.77M-100.98%-327K48.99%-2.24M
-Change in payables and accrued expense -96.96%44K132.86%757K-96.89%94K-132.03%-1.23M113.52%419K-39.83%1.45M-269.29%-2.3M121.07%3.02M253.14%3.83M-120.26%-3.1M
-Change in other current assets 53.37%-1.97M-165.55%-392K-124.63%-4.55M176.41%1.61M298.25%1.36M-818.54%-4.23M122.66%598K-380.22%-2.03M-219.06%-2.11M-193.84%-686K
-Change in other working capital -88.18%-8.28M28.25%-1.61M-23.12%-2.21M176.31%3.79M-377.20%-8.25M-152.56%-4.4M-123.13%-2.25M9.43%-1.8M240.00%1.37M-207.26%-1.73M
Cash from discontinued investing activities
Operating cash flow 13.43%-39.35M11.50%-11.87M48.19%-4.87M-80.89%-14.96M46.74%-7.66M-767.88%-45.46M-508.07%-13.41M-90.87%-9.4M-131.76%-8.27M-18.88%-14.38M
Investing cash flow
Cash flow from continuing investing activities 199.32%16.43M102.33%382K49,214.29%20.63M-13,351.43%-4.71M350.98%128K-290.66%-16.54M-468.69%-16.41M-100.90%-42K91.97%-35K-292.31%-51K
Net PPE purchase and sale 67.86%-45K66.67%-1K57.45%-20K103.33%3K---27K89.32%-140K99.43%-3K85.80%-47K79.50%-90K--0
Net intangibles purchase and sale --0---------------6K-1,204.35%-300K--------------0
Net investment purchase and sale 196.23%15.52M--0--20.1M-229,150.00%-4.59M--0-261.25%-16.13M-422.50%-16.13M--0---2K--2K
Cash from discontinued investing activities
Investing cash flow 199.32%16.43M102.33%382K49,214.29%20.63M-13,351.43%-4.71M350.98%128K-290.66%-16.54M-468.69%-16.41M-100.90%-42K91.97%-35K-292.31%-51K
Financing cash flow
Cash flow from continuing financing activities -41.57%25.16M22,445.45%9.92M-72.06%12.03M29,045.45%3.18M140.43%19K40.17%43.05M44K10,032.47%43.06M82.26%-11K-100.15%-47K
Net issuance payments of debt 8.42%-174K44.87%-43K-226.67%-49K32.00%-34K-2.13%-48K9.95%-190K-7,700.00%-78K-103.69%-15K90.04%-50K58.77%-47K
Net common stock issuance -41.42%25.33M8,066.39%9.96M-71.96%12.08M8,151.28%3.22M--67K39.83%43.24M12,100.00%122K226,626.32%43.08M-91.14%39K--0
Cash from discontinued financing activities
Financing cash flow -41.57%25.16M22,445.45%9.92M-72.06%12.03M29,045.45%3.18M140.43%19K40.17%43.05M--44K10,032.47%43.06M82.26%-11K-100.15%-47K
Net cash flow
Beginning cash position -25.46%54.82M-34.67%58.81M-42.36%29.72M-21.19%46.73M-25.46%54.82M167.90%73.54M25.95%90.02M-27.62%51.57M29.67%59.3M167.90%73.54M
Current changes in cash 111.79%2.24M94.75%-1.56M-17.34%27.79M-98.22%-16.48M48.12%-7.51M-141.02%-18.95M-1,425.23%-29.78M19,559.06%33.62M-132.56%-8.31M-179.34%-14.47M
Effect of exchange rate changes -1,424.56%-3.02M40.68%-3.22M-73.03%1.3M-190.92%-531K-348.28%-576K317.14%228K-2,929.61%-5.42M7,958.33%4.84M2,880.95%584K562.86%232K
End cash Position -1.43%54.03M-1.43%54.03M-34.67%58.81M-42.36%29.72M-21.19%46.73M-25.46%54.82M-25.46%54.82M25.95%90.02M-27.62%51.57M29.67%59.3M
Free cash flow 14.16%-39.4M13.45%-11.87M48.24%-4.89M-78.83%-14.95M46.52%-7.69M-938.74%-45.9M-397.68%-13.71M-79.75%-9.45M-132.66%-8.36M-18.74%-14.38M
Currency Unit GBPGBPGBPGBPGBPGBPGBPGBPGBPGBP
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg